GlaxoSmithKline is fined record $3bn in US.

Suppr

超能文献

作者信息

Roehr Bob

出版信息

BMJ. 2012 Jul 3;345:e4568. doi: 10.1136/bmj.e4568.

DOI:10.1136/bmj.e4568

PMID:22761252

Abstract

摘要

相似文献

GlaxoSmithKline is fined record $3bn in US.

BMJ. 2012 Jul 3;345:e4568. doi: 10.1136/bmj.e4568.

Targeting drug companies' bottom line.

Prescrire Int. 2011 Jan;20(112):25.

US pharma company fined 435 million dollars.

CMAJ. 2006 Oct 24;175(9):1046. doi: 10.1503/cmaj.061242.

Malfeasance on an industrial scale.

Prescrire Int. 2013 Feb;22(135):32.

Bias at the gate?: The pharmaceutical industry's influence on the federally approved drug compendia.

Am J Law Med. 2014;40(1):141-63. doi: 10.1177/009885881404000105.

The future of off-label marketing regulations in the post-Sorrell era.

Seton Hall Law Rev. 2013;43(3):1137-63.

An unhealthy disregard.

Nat Med. 2010 Jun;16(6):609. doi: 10.1038/nm0610-609.

Bitter pills for drug companies.

BMJ. 2010 Sep 17;341:c5095. doi: 10.1136/bmj.c5095.

Pharmaceuticals and medical devices: FDA oversight.

Issue Brief Health Policy Track Serv. 2012 Jan 3:1-86.

Company pays over $81m for allegedly promoting topiramate for unapproved uses.

BMJ. 2010 May 27;340:c2848. doi: 10.1136/bmj.c2848.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

GlaxoSmithKline is fined record $3bn in US.

BMJ. 2012 Jul 3;345:e4568. doi: 10.1136/bmj.e4568.

Targeting drug companies' bottom line.

Prescrire Int. 2011 Jan;20(112):25.

US pharma company fined 435 million dollars.

CMAJ. 2006 Oct 24;175(9):1046. doi: 10.1503/cmaj.061242.

Malfeasance on an industrial scale.

Prescrire Int. 2013 Feb;22(135):32.

Bias at the gate?: The pharmaceutical industry's influence on the federally approved drug compendia.

Am J Law Med. 2014;40(1):141-63. doi: 10.1177/009885881404000105.

The future of off-label marketing regulations in the post-Sorrell era.

Seton Hall Law Rev. 2013;43(3):1137-63.

An unhealthy disregard.

Nat Med. 2010 Jun;16(6):609. doi: 10.1038/nm0610-609.

Bitter pills for drug companies.

BMJ. 2010 Sep 17;341:c5095. doi: 10.1136/bmj.c5095.

Pharmaceuticals and medical devices: FDA oversight.

Issue Brief Health Policy Track Serv. 2012 Jan 3:1-86.

Company pays over $81m for allegedly promoting topiramate for unapproved uses.

BMJ. 2010 May 27;340:c2848. doi: 10.1136/bmj.c2848.